Jump to Content Jump to Main Navigation
User Account
  • Sign In to save searches and organize your favorite content.
  • Not registered? Sign up
  • My Content (0)
  • Searches (0)
More
  • Subscriptions
  • Join E-mail List
  • Help
JNCCN
Menu
  • Home
  • Content
    • Current Issue
    • Past Issues
    • Online First
    • Supplements
    • NCCN Meeting Highlights
    • JNCCN In the News
  • COVID-19
  • CE
  • JNCCN 360
  • Author Center
    • Call for Papers
    • Submit a Manuscript
    • Information for Authors
    • Reprints/Permissions
  • About
    • JNCCN
    • Editorial Board
    • Editorial Calendar
    • NCCN
    • Harborside
Search
Close
Advanced Search Help

Volume 17 (2019): Issue 11.5 (Nov 2019): Highlights of the NCCN 2019 Annual Congress

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
  • Get eTOC Alerts
  • Get Ahead of Print Alerts
  • Citation Alert
  • Highlights of the NCCN 2019 Annual Congress: Hematologic Malignancies
    • The NCCN 2019 Annual Congress: Hematologic Malignancies
    • Evolving Strategies in First-Line Chronic Lymphocytic Leukemia: Is There a Role for Chemoimmunotherapy?
    • Updates in Treatment Strategies for Hodgkin Lymphoma
    • Optimizing First-Line Therapy for Follicular Lymphoma: Is It Time for Chemotherapy-Free Approaches?
    • Diagnosis and Management of Castleman Disease
    • Patient Case Studies and Panel Discussion: Lymphoma
    • The Era of Therapeutic Biosimilars Has Arrived: What You Need to Know
    • Fixed-Duration Versus Until Disease Progression: How Long Should Initial Treatment of Multiple Myeloma Last?
    • Evolution of Therapy for Relapsed/Refractory Multiple Myeloma
    • Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms
    • Therapeutic Advances in First-Line Management of Acute Myeloid Leukemia
    • Advances in Personalized Therapeutic Approaches in Myelodysplastic Syndromes
    • Management of Recurrent Acute Lymphoblastic Leukemia With T-Cell Engagement: CAR T, BiTEs, and Beyond
    • Patient Case Studies and Panel Discussion: Leukemia – Rare and Emerging Subtypes
  • Collapse
  • Expand
  • Advertising
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Permissions
  • Disclaimer

© 2019-2020 National Comprehensive Cancer Network

Follow us on: Share Share Share

Powered by:

PubFactory
  • [18.234.247.75]
  • 18.234.247.75
Close
Edit

Character limit 500/500

@!

Character limit500/500